Apple Cider Vinegar Pills: Worthless and Potentially Harmful

Liquid apple cider vinegar (ACV) has a small, genuinely interesting evidence base for blood sugar after meals and, in one trial, mild weight loss. The effect sizes are small. ACV pills take that thin evidence and apply it to a completely different delivery vehicle without retesting the same endpoints. They also bring problems liquid does not have: large dose-to-dose differences in actual acetic acid content and documented esophageal burns when a capsule sticks and dissolves on the way down.

What the Liquid Evidence Actually Shows

The most-cited human trial of liquid ACV is Kondo 2009 (PMID 19661687) — a 12-week, double-blind RCT in 155 obese Japanese adults split into three groups. Daily intake of a 500 mL drink containing 15 mL or 30 mL of vinegar (about 750 or 1,500 mg of acetic acid) lowered body weight by roughly 1.0–1.7 kg compared with placebo. The drop was statistically significant but small enough to be clinically trivial. Blood-sugar trials are mostly short and small, and a 2024 umbrella review (Hadi et al.) concluded effects on fasting glucose and HbA1c are inconsistent and based on low-quality evidence. This is the ceiling of the evidence the pill industry leans on.

The Pill Problem

The proposed mechanisms for ACV — acetic acid slowing gastric emptying and blunting starch digestion — depend on acetic acid actually contacting the upper GI tract. Encapsulated pills dissolve in the stomach after most carb absorption is already underway, removing the timing the liquid form depends on. As of April 2026, no published clinical trial has shown that ACV capsules reproduce the metabolic effects that liquid vinegar sometimes shows. The pills bolt an untested delivery format onto an already weak evidence base.

The Harm Profile

Vinegar in any form is acidic enough (pH around 2.5–3.0) to erode dental enamel and irritate the esophagus. Hill 2005 (PMID 15983536) tested 8 ACV tablet brands and found wide variation in tablet size, pH, and labeled vs. measured acid content — with serious doubt that ACV was even the actual ingredient in some brands. The same paper documents an esophageal injury case caused by an ACV tablet that lodged in the esophagus and burned the lining as it dissolved. High intakes have also been linked to low blood potassium (hypokalemia) in case reports, especially relevant for people on diuretics, digoxin, or insulin.

The bottom line: ACV pills add no proven benefit over the already-limited liquid form and bring real safety concerns — including unpredictable dosing and the risk of an esophageal burn. They are not worth buying.